Fabian Grundmann

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIM The most recent European Society of Cardiology (ESC) update on atrial fibrillation has introduced vernakalant (VER) for pharmacological cardioversion of atrial fibrillation. The aim of the(More)
BACKGROUND Ranolazine inhibits late Na(+) and K(+) currents. Earlier studies have reported an antiarrhythmic effect. The aim of the present study was to understand whether ranolazine could still(More)
  • 1